Sign Out
Prismasol B0 may be warmed to 37 °C to enhance patient comfort. Warming of the solution prior to use should be done before reconstitution with dry heat only. Solutions should not be heated in water or in a microwave oven. The solution should be inspected visually for particulate matter and discoloration prior to administration, whenever solution and container permit. Do not administer unless the solution is clear and the seal is intact.
Before and during treatment, electrolyte and acid-base balance should be closely monitored throughout the procedure.
Phosphate up to 1.2 mmol/L may be added to the solution. If potassium phosphate is added, the total potassium concentration should not exceed 4 mEq/L (4 mmol/L). Potassium supplement might be necessary.
The patient's hemodynamic status and fluid balance should be monitored throughout the procedure and corrected as needed.
Effects on ability to drive and use machines: Not relevant.
Fertility: There are no clinical data on fertility. However no effects on fertility are anticipated.
Use in Children: There are no specific warnings and precautions when using this medicine for children.
